Breadcrumb

MEDIA_REFRESH_DATA_PRESS_RELEASE

Media

U.S. News Room

Press Releases

News, Events, Updates, Breakthroughs

Journalists may direct questions to mediainquiries@dsi.com. Or click here for direct contact information for Daiichi Sankyo U.S. Public Affairs team

Press announcements are archived by release date, searchable by topic:

Fri Jan 17 00:00:00 GMT-05:00 2025 NEW
DATROWAY® Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer Download
Mon Jan 13 00:00:00 GMT-05:00 2025 NEW
Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH Download
Mon Jan 13 00:00:00 GMT-05:00 2025 NEW
Datopotamab Deruxtecan Granted Priority Review in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer Download
Tue Dec 10 00:00:00 GMT-05:00 2024
QuANTUM-Wild Phase 3 Trial of VANFLYTA® Initiated in Patients with Newly Diagnosed FLT3-ITD Negative AML Download
Mon Dec 09 00:00:00 GMT-05:00 2024
Daiichi Sankyo Statement on the Passing of Toshinori Agatsuma, PhD Download
Mon Dec 09 00:00:00 GMT-05:00 2024
Datopotamab Deruxtecan Granted Breakthrough Therapy Designation in U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer Download
Thu Dec 05 00:00:00 GMT-05:00 2024
Datopotamab Deruxtecan Demonstrated Meaningful Clinical Activity in Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer in TROPION-Lung05 and TROPION-Lung01 Pooled Analysis Download
Mon Dec 02 00:00:00 GMT-05:00 2024
Daiichi Sankyo Highlights Progress Across Oncology Portfolio in Multiple Solid and Blood Cancers at ESMO Asia, SABCS and ASH Download
Fri Nov 22 00:00:00 GMT-05:00 2024
Daiichi Sankyo Joins with LabCentral Community as Platinum Sponsor Download
Wed Nov 13 00:00:00 GMT-05:00 2024
Daiichi Sankyo to Showcase TURALIO® Research in Patients with Tenosynovial Giant Cell Tumor at CTOS Download
Showing 1 - 10 of 177 results.